CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

von Willebrand Factor (VWF) Concentrates

Phase 3
Roche Holding AG (RHHBY)

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
RHHBYPhase 3

von Willebrand Factor (VWF) Concentrates Phase 3 Est. Readout

von Willebrand Factor (VWF) Concentrates
Q2 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Von Willebrand Disease, Type 3

View Full Landscape
Drug Information

Target Indication

Von Willebrand Disease, Type 3

Clinical Trial

NCT06998524

Last updated: 3/7/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.